cystathionine beta synthase inhibitors (Fondation Jerome Lejeune)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namecystathionine beta synthase inhibitors (Fondation Jerome Lejeune)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCystathionine beta-synthase inhibitors
TargetsCystathionine beta-synthase
Therapy Area/IndicationsDown Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFondation Jérôme Lejeune
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFondation Jérôme Lejeune
Active IndicationsN/A
Inactive IndicationsDown Syndrome

Other Information

ATC CodeN/A
Related LinksN/A